Published in J Pept Sci on February 25, 2013
Receptor binding peptides for target-selective delivery of nanoparticles encapsulated drugs. Int J Nanomedicine (2014) 0.85
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer. Biomed Res Int (2015) 0.82
Nanoparticle ligand presentation for targeting solid tumors. AAPS PharmSciTech (2014) 0.80
A marine analgesic peptide, Contulakin-G, and neurotensin are distinct agonists for neurotensin receptors: uncovering structural determinants of desensitization properties. Front Pharmacol (2015) 0.77
Liposomes derivatized with multimeric copies of KCCYSL peptide as targeting agents for HER-2-overexpressing tumor cells. Int J Nanomedicine (2017) 0.75
A new nerve growth factor-mimetic peptide active on neuropathic pain in rats. J Neurosci (2008) 1.25
Synthetic peptides in the form of dendrimers become resistant to protease activity. J Biol Chem (2003) 1.20
Identification of an antiangiogenic FGF2-binding site in the N terminus of the soluble pattern recognition receptor PTX3. J Biol Chem (2006) 1.10
Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. Antimicrob Agents Chemother (2005) 1.06
Molecular basis of branched peptides resistance to enzyme proteolysis. Chem Biol Drug Des (2007) 1.03
Comparison of the binding and internalization properties of 12 DOTA-coupled and ¹¹¹In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607. Eur J Nucl Med Mol Imaging (2011) 1.00
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. FASEB J (2009) 1.00
Prediction of quaternary assembly of SARS coronavirus peplomer. Biochem Biophys Res Commun (2004) 1.00
Physicochemical properties of mixed micellar aggregates containing CCK peptides and Gd complexes designed as tumor specific contrast agents in MRI. J Am Chem Soc (2004) 0.99
Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis. Infect Immun (2003) 0.98
In vitro and in vivo evaluation of 111In-DTPAGlu-G-CCK8 for cholecystokinin-B receptor imaging. J Nucl Med (2004) 0.98
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting. Mol Cancer Ther (2007) 0.98
Supramolecular aggregates of amphiphilic gadolinium complexes as blood pool MRI/MRA contrast agents: physicochemical characterization. Langmuir (2006) 0.97
Bioactive peptides from libraries. Chem Biol (2005) 0.96
Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607. Eur J Nucl Med Mol Imaging (2011) 0.95
Branched peptides as therapeutics. Curr Protein Pept Sci (2008) 0.94
Three-dimensional computation of atom depth in complex molecular structures. Bioinformatics (2005) 0.93
Identification of new Th peptides from the cytomegalovirus protein pp65 to design a peptide library for generation of CD4 T cell lines for cellular immunoreconstitution. Int Immunol (2004) 0.92
Clickable functionalization of liposomes with the gH625 peptide from Herpes simplex virus type I for intracellular drug delivery. Chemistry (2011) 0.92
Design and in vitro evaluation of branched peptide conjugates: turning nonspecific cytotoxic drugs into tumor-selective agents. ChemMedChem (2010) 0.92
Target-selective drug delivery through liposomes labeled with oligobranched neurotensin peptides. ChemMedChem (2011) 0.91
Rational design and molecular diversity for the construction of anti-alpha-bungarotoxin antidotes with high affinity and in vivo efficiency. Chem Biol (2003) 0.90
Nanostructures by self-assembling peptide amphiphile as potential selective drug carriers. Biopolymers (2007) 0.89
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. J Med Chem (2013) 0.87
Selective occlusion of tumor blood vessels by targeted delivery of an antibody-photosensitizer conjugate. Int J Cancer (2006) 0.87
Peptide-containing aggregates as selective nanocarriers for therapeutics. ChemMedChem (2008) 0.87
Characterization of the branched antimicrobial peptide M6 by analyzing its mechanism of action and in vivo toxicity. J Pept Sci (2007) 0.87
Micelles derivatized with octreotide as potential target-selective contrast agents in MRI. J Pept Sci (2009) 0.87
The development of antimicrobial peptides as new antibacterial drugs. Curr Protein Pept Sci (2013) 0.86
Structure-activity relationships and mechanism of action of Eph-ephrin antagonists: interaction of cholanic acid with the EphA2 receptor. ChemMedChem (2012) 0.86
Structure-activity relations of myxinidin, an antibacterial peptide derived from the epidermal mucus of hagfish. Antimicrob Agents Chemother (2013) 0.85
Peptide modified nanocarriers for selective targeting of bombesin receptors. Mol Biosyst (2010) 0.85
Peptide inhibitors against herpes simplex virus infections. J Pept Sci (2013) 0.85
Criteria for the design and biological characterization of radiolabeled peptide-based pharmaceuticals. BioDrugs (2004) 0.85
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo. Biochem J (2006) 0.85
Nanoparticles containing octreotide peptides and gadolinium complexes for MRI applications. J Pept Sci (2010) 0.84
Strategies for the construction and use of peptide and antibody libraries displayed on phages. Curr Protein Pept Sci (2004) 0.84
High-relaxivity supramolecular aggregates containing peptides and Gd complexes as contrast agents in MRI. J Biol Inorg Chem (2006) 0.82
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin. Biochemistry (2002) 0.82
Models of In-Vivo Bacterial Infections for the Development of Antimicrobial Peptide-based Drugs. Curr Top Med Chem (2017) 0.81
Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent. Int J Nanomedicine (2012) 0.81
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions. Amino Acids (2011) 0.81
Peptide-protein interactions studied by surface plasmon and nuclear magnetic resonances. FEBS Lett (2002) 0.81
Structural and relaxometric characterization of peptide aggregates containing gadolinium complexes as potential selective contrast agents in MRI. Chemphyschem (2007) 0.81
Antimicrobial peptides as an opportunity against bacterial diseases. Curr Med Chem (2015) 0.80
NMR studies of lysozyme surface accessibility by using different paramagnetic relaxation probes. J Am Chem Soc (2006) 0.80
Isomerization of an antimicrobial peptide broadens antimicrobial spectrum to gram-positive bacterial pathogens. PLoS One (2012) 0.80
Oligo-branched peptides for tumor targeting: from magic bullets to magic forks. Expert Opin Biol Ther (2009) 0.80
Peptide-labeled supramolecular aggregates as selective doxorubicin carriers for delivery to tumor cells. Biopolymers (2011) 0.80
Peptide derivatized lamellar aggregates as target-specific MRI contrast agents. Chembiochem (2007) 0.80
NMR studies of BPTI aggregation by using paramagnetic relaxation reagents. Biochim Biophys Acta (2006) 0.80
Exploitation of viral properties for intracellular delivery. J Pept Sci (2014) 0.80
NMR structure of alpha-bungarotoxin free and bound to a mimotope of the nicotinic acetylcholine receptor. Biochemistry (2002) 0.80
Branched peptides as novel tumor-targeting agents for bladder cancer. Expert Rev Anticancer Ther (2012) 0.80